APL-2401

N/A

Report date: 2025/09/03 17:58:19
NME

Base Information

Drug NameAPL-2401
Drug Alias NameAPL-2401
ClassificationSmall molecules
Mechanisms of ActionFibroblast growth factor receptor 2 antagonistsFibroblast growth factor receptor 3 antagonists
TargetsFibroblast growth factor receptor 2Fibroblast growth factor receptor 3
Therapy Area/IndicationsUrologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAsieris Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAsieris Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsUrologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A